[go: up one dir, main page]

AU2002327340A1 - 3-pyridylether rerivatives and their use as analgesics - Google Patents

3-pyridylether rerivatives and their use as analgesics

Info

Publication number
AU2002327340A1
AU2002327340A1 AU2002327340A AU2002327340A AU2002327340A1 AU 2002327340 A1 AU2002327340 A1 AU 2002327340A1 AU 2002327340 A AU2002327340 A AU 2002327340A AU 2002327340 A AU2002327340 A AU 2002327340A AU 2002327340 A1 AU2002327340 A1 AU 2002327340A1
Authority
AU
Australia
Prior art keywords
rerivatives
pyridylether
analgesics
pyridylether rerivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002327340A
Inventor
Imad M. Damaj
Malgozata Dukat
Richard A. Glennon
Billy R. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Publication of AU2002327340A1 publication Critical patent/AU2002327340A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002327340A 2001-07-31 2002-07-25 3-pyridylether rerivatives and their use as analgesics Abandoned AU2002327340A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30855701P 2001-07-31 2001-07-31
US60/308,557 2001-07-31
PCT/US2002/023686 WO2003011828A2 (en) 2001-07-31 2002-07-25 3-pyridylether rerivatives and their use as analgesics

Publications (1)

Publication Number Publication Date
AU2002327340A1 true AU2002327340A1 (en) 2003-02-17

Family

ID=23194447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002327340A Abandoned AU2002327340A1 (en) 2001-07-31 2002-07-25 3-pyridylether rerivatives and their use as analgesics

Country Status (2)

Country Link
AU (1) AU2002327340A1 (en)
WO (1) WO2003011828A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118279A (en) * 1995-06-07 2006-10-05 Abbott Lab 3 - pyridyloxy (or thio) alkyl heterocyclic compounds, pharmaceutical compositions containing them and their uses in the preparation of medicaments for controlling chemical synaptic transmission

Also Published As

Publication number Publication date
WO2003011828A3 (en) 2003-10-16
WO2003011828A2 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2002302419A1 (en) Substituted Pyrazolopyrimidines and thiazolopyrimidines used as analgesics
AU2002359163A1 (en) New use
AU2002356664A1 (en) Beta-amino-alpha-cyanoacrylates and their use as herbicides
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002211717A1 (en) Stresscopins and their uses
IL154553A0 (en) Urocortin-iii and uses thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002324450A1 (en) Novel pyridopyrimidines and uses thereof
AU2002343489A1 (en) Nociceptin-based analgesics
AU4432001A (en) Trityl-type compounds and their use
AU2001277519A1 (en) Bio-probes and use thereof
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002331114A1 (en) Tetrahydroisochinolines, their production and the use thereof as analgesics
EP1367123A4 (en) Neurotonin and use thereof
AU2002327340A1 (en) 3-pyridylether rerivatives and their use as analgesics
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
AU2002228426A1 (en) Neurotonin and use thereof
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase